Immune Complex Epitope Mapping With EM for Polyclonal Antibodies
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing humoral immune responses, such as serum neutralization assays and deep sequencing, are time-consuming, costly, and limited in their ability to detail the specificities of antibodies elicited by immunization, particularly for polyclonal responses, leading to incomplete understanding of vaccine efficacy and failure analysis.
Innovation Solution
A method involving immunization, serum collection, and imaging of immune complexes by electron microscopy to map epitopes recognized by antibodies, allowing for rapid characterization and quantification of antibody responses, including the use of next-generation sequencing and mass spectrometry for comprehensive analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If monoclonal antibodies are generated and structural analysis is performed to gain detailed picture of immunogen complex, then measurement precision of epitope mapping is improved, but time consumption and cost increase significantly
Solution Approach 1:
The patent replaces the mechanical/biochemical process of monoclonal antibody generation and structural determination with electron microscopy imaging. The EM technique directly visualizes immune complexes in near-native states, providing epitope mapping information without requiring monoclonal antibody production, thereby dramatically reducing time and cost while maintaining precision.
Solution Approach 2:
The patent creates visual copies (images) of immune complexes through electron microscopy. These images serve as direct representations of the antibody-antigen interactions, allowing researchers to map epitopes by analyzing the visualized complexes rather than through time-consuming biochemical characterization of monoclonal antibodies.
2Measurement precision
If monoclonal antibodies are generated from polyclonal antibodies for structural determination, then epitope specificity is improved, but productivity of immune response analysis decreases
Solution Approach 1:
The patent makes electron microscopy a universal tool that can analyze both polyclonal and monoclonal antibody responses simultaneously. The EM methodology provides a single platform that delivers epitope mapping information for diverse antibody types without requiring separate processing workflows, thereby increasing productivity while maintaining specificity.
Solution Approach 2:
The patent substitutes the multi-step process of monoclonal antibody generation with direct EM imaging of polyclonal immune complexes. This replacement maintains the ability to identify specific epitope recognitions while dramatically increasing throughput by eliminating the time-consuming monoclonal isolation and characterization steps.
3Loss of information
If detailed structural analysis is performed on successful vaccine responses, then understanding of immune response is improved, but analysis of unsuccessful vaccination experiments becomes prohibitively costly and time-consuming
Solution Approach 1:
The patent applies electron microscopy to rapidly analyze both successful and unsuccessful vaccine responses. The direct imaging approach provides comprehensive immune complex visualization without the time and cost constraints that previously prevented detailed analysis of failed vaccinations, enabling researchers to extract valuable information from negative results.
Solution Approach 2:
The EM methodology allows immune complexes to be visualized in their native state without requiring extensive purification or manipulation. This self-service approach preserves information from unsuccessful vaccine attempts that would otherwise be lost due to the complexity and cost of traditional analysis methods.
4Loss of information
If conventional epitope mapping methods are used, then comprehensive coverage of antibody responses is improved, but cost and time requirements increase
Solution Approach 1:
The patent replaces resource-intensive biochemical methods with electron microscopy imaging. The EM technique provides comprehensive coverage of antibody responses by visualizing diverse immune complexes simultaneously, reducing consumption of reagents, materials, and associated resources while maintaining information completeness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables real-time analysis of ongoing immunization experiments, provides detailed insights into antibody responses, and offers cues for improving vaccine candidates, facilitating structure-guided immunogen design and rapid evaluation of vaccine immunogenicity.
Implementation Method 1
imaging, by electron microscopy, the sera obtained from the immunized subject in each of the time intervals, to obtain structural images of the one or more immune complexes
Data Source
AI summary
Provided herein are methods of forming immune complexes for analyzing immunity against a specific antigen or pathogen in an immunized or infected subject. The methods entail isolating polyclonal immunoglobulin (Ig) molecules from a blood or serum sample from an immunized or infected subject, enzymatically digesting the polyclonal Ig molecules to generate Fab molecules, and contacting the Fab molecules with a soluble pathogen and/or antigen of interest, and identifying one or more immune complexes formed between the pathogen and/or antigen and the Fab molecules.